As the Ebola Emergency Outbreak Grows Rapidly, NanoViricides Has Proposed a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment – with Superior Oral Administration ...

SHELTON, CT / ACCESS Newswire / June 8, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical ...
Clinical Trials Arena on MSN

J&J’s nipocalimab meets primary endpoint in Phase II JASMINE study

The study is said to be the first to demonstrate efficacy for FcRn inhibition in SLE.

ATS 2026: DPP1 inhibitors reinforced with Phase II final pooled data from verducatib

The results provide validation of the DPP1 inhibition in bronchiectasis and reinforce the drug class’s position in this ...
ascopubs.org

Dual targeting of VEGF and PD-1: A phase I/II trial of ivonescimab, a novel bispecific antibody, in recurrent glioblastoma.

Update on GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...
wvgazettemail.com

OriCell's GPC3 CAR-T Receives NMPA Clearance for Confirmatory Phase II Trial in Late-Line Advanced Hepatocellular Carcinoma

OriC ( The "Company" or "Oricell") , announced that its proprietary GPC3-targeted autologous CAR-T therapy, Ori-C101, has received clearance from China's ...